SCHEMBL2489144

SCHEMBL2489144

COc1ccc(C(NCCO)(c2ccc(OC)cc2)c2ccc(OC)cc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.45
ALDH1A1 P00352 3/20 0.45
MAPK1 P28482 3/20 0.45
RECQL P46063 2/20 0.45
TDP1 Q9NUW8 2/20 0.45
ALOX15 P16050 1/20 0.45
APEX1 P27695 1/20 0.45
HSD17B10 Q99714 1/20 0.45
MAPT P10636 4/20 0.44
GAA P10253 3/20 0.44
CA1 P00915 3/20 0.43
CA2 P00918 3/20 0.43
CA12 O43570 1/20 0.42
CA7 P43166 1/20 0.42
CA9 Q16790 1/20 0.42
CA14 Q9ULX7 1/20 0.42
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
AOC3 Q16853 1/20 0.41
L3MBTL1 Q9Y468 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4363002 0.93 KIF11 (0.49) LMNAALDH1A1MAPK1MAPTGAA
SCHEMBL12225852 0.93 KIF11 (0.49) LMNAALDH1A1MAPK1MAPTGAA
SCHEMBL2490249 0.91 NPC1 (0.42) LMNAALDH1A1MAPK1RECQLTDP1
SCHEMBL9439820 0.85 KIF11 (0.47) LMNAMEN1KMT2AKDM4EHTT
SCHEMBL10309879 0.83 KIF11 (0.45) LMNANPC1RAB9AMEN1KMT2A
SCHEMBL4156500 0.83 NPC1 (0.43) LMNAALDH1A1MAPK1RECQLTDP1
SCHEMBL6302955 0.83 KIF11 (0.45) LMNANPC1RAB9AMEN1KMT2A
SCHEMBL8053146 0.83 KIF11 (0.45) LMNANPC1RAB9AMEN1KMT2A
SCHEMBL19783888 0.81 KIF11 (0.45) LMNAALDH1A1NPC1RAB9AMEN1
SCHEMBL13772987 0.80 ACHE (0.52) LMNAALDH1A1MAPK1RECQLTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3009123-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2016-04-20 EP disclosed
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2015-11-19 US disclosed
EP-2845587-A2 Melanin production inhibitor Pola Chemical Industries Inc. (JP) 2015-03-11 EP disclosed
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2014-12-11 US disclosed
US-8846012-B2 Melanin production inhibitor POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-30 US disclosed
EP-2380567-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2011-10-26 EP disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, TH LMNA 2547/4885ALDH1A1 1292/4885MAPK1 172/4885
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR TYR, MC1R, F12 LMNA 2843/4885ALDH1A1 1031/4885MAPK1 221/4885
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, MC1R LMNA 2187/4885ALDH1A1 1187/4885MAPK1 194/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.